GRBIOMEM2508 - CMLE - Navigating Biomarker Testing in Hematologic Malignancies

Course Description

Navigating Biomarker Testing in Hematologic Malignancies

This is an elective module of the Biomarker Testing Navigation Certificate program.  This online, interactive module focuses on the crucial role of biomarker testing in hematologic malignancies. It emphasizes that the timely and accurate delivery of these test results to clinicians is vital for guiding critical treatment decisions. Participants will gain skills in prioritizing tests, interpreting biomarker results, and optimizing workflows specifically for blood cancers. Participants will learn to align biomarkers with therapies, address challenges, and implement NCCN/ASCO guidelines. 

Course topics include: 

Biomarkers in hematologic malignancies

Applying guidelines and best practices for biomarker testing in hematologic malignancies

Further directions and emerging biomarkers

Target Audience 

This activity has been designed to meet the educational needs of pathologists and laboratory professionals. 

Faculty/Authors

Ghazal Khan, MBA 
Anatomic Pathology Manager, University of Illinois Health 
Chicago, Illinois 

Physician's Competency: Patient Care, Medical Knowledge

CMLE Credit: 1.5
Estimated Completion Time: 1.5 hour
Format: Online educational activity

Credit Designation Statement

ASCP designates this activity for a maximum of 1.5 CMLE credit. This activity meets CMP and state re-licensure requirements for laboratory personnel.

For questions regarding CMLE credit, please contact ASCP Customer Service at 1-800-267-2727, option 2, in the US & Canada or internationally at access code + 3-1-312-541-4890. Monday-Friday, 8am-5pm CT.

Method of Participation
To complete the activity and receive credit, the participant must complete the online activity. CMLE certificates will be provided online.

Commercial Support
This activity is supported by a sponsorship from AstraZeneca.

Instructions

To claim CMLE credit for the exercise, do the following:

Review the Technical Considerations.
Click Go to Content and click the first module of the course.
Complete the Demographic Survey.
Complete the Pre-Test.
Review the Educational Activity.
Complete and submit the Post Exam. You will have a maximum of three attempts to obtain the required score. You will be notified if you have met the credit requirements after each attempt.
Submit the course Evaluation.
Enter the maximum number of credits offered and click Claim CMLE to register credit.

Faculty Disclosures

Technical Considerations

Release Dates: 10/6/2025
Review Date:
Expiration Date: 6/10/2028

Course Objectives

Upon completion of this activity, you will be able to:

Specify five key types of hematologic malignancies

Differentiate between specific biomarker types in hematologic malignancies and their roles in diagnosis, prognosis and therapy selection.

Identify specific biomarker-directed therapies and their applications across hematologic malignancies.

Integrate current guidelines and best practices into the prioritization and evaluation of biomarker testing for hematologic malignancies.

Assess emerging technologies to optimize biomarker testing strategies for hematologic malignancies.

Summary

Availability:

On-Demand

Credit Offered:

1.5 CMLE Credits